Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
Clinical trial NCT03514069 · COMPLETED
Trial details
- NCT number
- NCT03514069
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-05
- Primary completion
- 2021-08-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.